发明名称 EPOTHILONE DERIVATIVES
摘要 The present invention relates to compounds of the formula Q is selected from the group consisting of G is selected from the group consisting of alkyl, substituted alkyl, substituted or unsubstituted aryl, heterocyclo, W is O or NR<SUB>15</SUB>; X is O or H,H; Y is selected from the group consisting of O; H,OR<SUB>16</SUB>; OR<SUB>17</SUB>,OR<SUB>17</SUB>; NOR<SUB>18</SUB>; H,NOR<SUB>19</SUB>; H,NR<SUB>20</SUB>R<SUB>21</SUB>; H,H; or CHR<SUB>22</SUB>; OR<SUB>17</SUB>OR<SUB>17 </SUB>can be a cyclic ketal; Z<SUB>1 </SUB>and Z<SUB>2 </SUB>are selected from the group consisting of CH<SUB>2</SUB>, O, NR<SUB>23</SUB>, S, or SO<SUB>2</SUB>, wherein only one of Z and Z<SUB>2 </SUB>is a heteroatom; B<SUB>1 </SUB>and B<SUB>2 </SUB>are selected from the group consisting of OR<SUB>24</SUB>, or OCOR<SUB>25</SUB>, or O<SUB>2</SUB>CNR<SUB>26</SUB>R<SUB>27</SUB>; when B<SUB>1 </SUB>is H and Y is OH, H they can form a six-membered ring ketal or acetal; D is selected from the group consisting of NR<SUB>28</SUB>R<SUB>29</SUB>, NR<SUB>30</SUB>COR<SUB>31 </SUB>or saturated heterocycle; R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>5</SUB>, R<SUB>6</SUB>, R<SUB>7</SUB>, R<SUB>13</SUB>, R<SUB>14</SUB>, R<SUB>18</SUB>, R<SUB>19</SUB>, R<SUB>20</SUB>, R<SUB>21</SUB>, R<SUB>22</SUB>, R<SUB>26</SUB>, and R<SUB>27 </SUB>are selected from the group H, alkyl, substituted alkyl, or aryl and when R<SUB>1 </SUB>and R<SUB>2 </SUB>are alkyl can be joined to form a cycloalkyl; R<SUB>3 </SUB>and R<SUB>4 </SUB>are alkyl can be joined to form a cycloalkyl; R<SUB>9</SUB>, R<SUB>10</SUB>, R<SUB>16</SUB>, R<SUB>17</SUB>, R<SUB>24</SUB>, R<SUB>25</SUB>, and R<SUB>31 </SUB>are selected from the group H, alkyl, or substituted alkyl; R<SUB>8</SUB>, R<SUB>11</SUB>, R<SUB>12</SUB>, R<SUB>28</SUB>, R<SUB>30</SUB>, R<SUB>32</SUB>, R<SUB>33</SUB>, and R<SUB>30 </SUB>are selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, or heterocyclo; R<SUB>15</SUB>, R<SUB>23 </SUB>and R<SUB>29 </SUB>are selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, cycloalkyl, heterocyclo, R<SUB>32</SUB>C-O, R<SUB>33</SUB>SO<SUB>2</SUB>, hydroxy, O-alkyl or O-substituted alkyl, the pharmaceutically acceptable salts thereof and any hydrates, solvates or geometric, optical and stereoisomers thereof, with the proviso that compounds wherein W and X are both O; and R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>7</SUB>, are H; and R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>6</SUB>, are methyl; and R<SUB>8</SUB>, is H or methyl; and Z<SUB>1</SUB>, and Z<SUB>2</SUB>, are CH<SUB>2</SUB>; and G is 1-methyl-2-(substituted-4-thiazolyl)ethenyl; and Q is as defined above are excluded.
申请公布号 US2007255055(A1) 申请公布日期 2007.11.01
申请号 US20070763636 申请日期 2007.06.15
申请人 发明人 VITE GREGORY D.;KIM SOONG-HOON;BORZILLERI ROBERT M.;JOHNSON JAMES A.
分类号 C07D225/02;C07D491/044;A61K31/335;A61K31/395;A61K31/427;A61P19/00;A61P35/00;A61P43/00;C07D225/00;C07D273/00;C07D277/26;C07D313/00;C07D417/06;C07D417/08;C07D491/04;C07D493/04;C07D498/04 主分类号 C07D225/02
代理机构 代理人
主权项
地址